AGYS
BEARISH
$68.49
Live
Agilysys, Inc. · NASDAQ
Target $138.0
(+101.5%)
$63.71
52W Range
$145.25
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Mar 14, 2026
Market cap
$1.93B
P/E
64.01
ROE
10.7%
Profit margin
9.8%
Debt/Equity
0.06
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
85%
AGYS exhibits strong deterministic health with a Piotroski F-Score of 7/9, indicating solid operational and financial stability, though the absence of an Altman Z-Score raises concern about bankruptcy risk assessment. The stock trades at a premium valuation with a current P/E of 64.01 and forward P/E of 31.50, significantly above the sector average of 77.74, suggesting high growth expectations are already priced in. Despite robust revenue and earnings growth (15.6% and 152.8% YoY respectively), the 6-month price decline of 35.3% and 1-month drop of 20.0% reflect strong bearish technical momentum. The Graham Number of $16.4 and intrinsic value of $31.57 suggest deep undervaluation, but the current price of $68.49 implies a substantial growth premium, making the stock vulnerable to downward revisions if growth slows.
Key Strengths
Piotroski F-Score of 7/9 indicates strong financial and operational health
High gross margin of 61.67% reflects strong pricing power and cost control
Low debt/equity ratio of 0.06 signals minimal financial leverage risk
Strong earnings growth of 152.8% YoY demonstrates significant profitability expansion
Positive insider sentiment at 40/100 suggests some confidence from insiders
Key Risks
Current price of $68.49 is nearly 4.2x the Graham Number ($16.4), indicating extreme overvaluation unless sustained high growth is guaranteed
Forward P/E of 31.50 is high relative to historical and sector norms, increasing downside risk if earnings fail to meet expectations
Technical trend score of 0/100 reflects strong bearish momentum, with 6-month and 1-month price declines of 35.3% and 20.0% respectively
No Altman Z-Score available, limiting assessment of bankruptcy risk despite strong balance sheet metrics
Dividend strength of 0/100 and lack of payout history suggest no income appeal, reducing investor base appeal
AI Fair Value Estimate
Based on comprehensive analysis
$31.57
-53.9% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
52
Moderate
45
85
55
75
0
AI Verdict
cautiously optimistic
Key drivers: Strong Piotroski F-Score and low leverage, High growth in revenue and earnings, High forward P/E suggests growth premium, Bearish technical trend and valuation premium
Confidence
80%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- Graham Number of $16.4 suggests defensive fair value
- Intrinsic value of $31.57 provides a baseline floor
Watchpoints
- Current price of $68.49 is 2.17x intrinsic value and 4.2x Graham Number
- P/E of 64.01 is significantly above sector average of 77.74
- Price/Sales of 6.20 indicates high valuation relative to revenue
Future
85/100
Ref Growth rates
Positives
- 152.8% YoY earnings growth and 15.6% revenue growth indicate strong momentum
- Q/Q earnings growth of 158.4% suggests acceleration
- Forward P/E of 31.50 implies high growth expectations are priced in
Watchpoints
- Sustained high growth is difficult to maintain at this scale
- Sector average revenue growth is 55.69%, but AGYS is outperforming, raising sustainability concerns
Past
55/100
Ref Historical trends
Positives
- 5-year return of +17.1% shows long-term appreciation
- Piotroski F-Score of 7/9 indicates consistent financial health
Watchpoints
- 3-year return of -15.7% and 1-year return of -4.1% indicate underperformance
- 6-month return of -35.3% and 1-month return of -20.0% show recent deterioration
Health
75/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 7/9 indicates strong financial health
- Debt/Equity of 0.06 is extremely low
- Current and quick ratios of 1.31 and 1.17 are healthy
Watchpoints
- No Altman Z-Score available, limiting distress risk assessment
- Lack of cash and debt data prevents full liquidity analysis
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend yield and payout ratio are both 0
- No dividend history or income appeal
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$68.49
Analyst Target
$138.0
Upside/Downside
+101.5%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AGYS and closest competitors.
Updated 2026-03-13
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AGYS
Agilysys, Inc.
Primary
|
+17.1% | -15.7% | -4.1% | -35.3% | -20.0% | -11.6% |
|
MXL
MaxLinear, Inc.
Peer
|
-42.6% | -31.6% | +117.8% | +27.7% | +24.5% | +17.1% |
|
ALKT
Alkami Technology, Inc.
Peer
|
-58.1% | +42.7% | -28.7% | -28.8% | +6.8% | +5.5% |
|
FORTY
Formula Systems (1985) Ltd.
Peer
|
+46.6% | +103.2% | +45.4% | -16.8% | -2.9% | -0.3% |
|
APPN
Appian Corporation
Peer
|
-85.0% | -37.5% | -11.8% | -16.9% | +9.3% | -3.9% |
AGY
Agilysys, Inc.
Primary
5Y
+17.1%
3Y
-15.7%
1Y
-4.1%
6M
-35.3%
1M
-20.0%
1W
-11.6%
MXL
MaxLinear, Inc.
Peer
5Y
-42.6%
3Y
-31.6%
1Y
+117.8%
6M
+27.7%
1M
+24.5%
1W
+17.1%
ALK
Alkami Technology, Inc.
Peer
5Y
-58.1%
3Y
+42.7%
1Y
-28.7%
6M
-28.8%
1M
+6.8%
1W
+5.5%
FOR
Formula Systems (1985) Ltd.
Peer
5Y
+46.6%
3Y
+103.2%
1Y
+45.4%
6M
-16.8%
1M
-2.9%
1W
-0.3%
APP
Appian Corporation
Peer
5Y
-85.0%
3Y
-37.5%
1Y
-11.8%
6M
-16.9%
1M
+9.3%
1W
-3.9%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
64.01
Forward P/E
31.5
PEG Ratio
N/A
P/B Ratio
6.13
P/S Ratio
6.2
EV/Revenue
5.98
EV/EBITDA
50.32
Market Cap
$1.93B
Profitability
Profit margins and return metrics
Profit Margin
9.79%
Operating Margin
10.78%
Gross Margin
61.67%
ROE
10.68%
ROA
4.01%
Growth
Revenue and earnings growth rates
Revenue Growth
+15.6%
Earnings Growth
+152.8%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
+158.4%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.06
Low debt
Current Ratio
1.31
Good
Quick Ratio
1.17
Good
Cash/Share
$2.91
Technology Sector Comparison
Comparing AGYS against 383 companies in the Technology sector
(32 bullish, 137 neutral, 214 bearish)
P/E Ratio
64.01
This Stock
vs
97.74
Sector Avg
-34.5%
(Discount)
Return on Equity (ROE)
10.68%
This Stock
vs
-35.13%
Sector Avg
-130.4%
(Below Avg)
Profit Margin
9.79%
This Stock
vs
-11.73%
Sector Avg
-183.5%
(Weaker)
Debt to Equity
0.06
This Stock
vs
0.67
Sector Avg
-90.4%
(Less Debt)
Revenue Growth
15.6%
This Stock
vs
6431.4%
Sector Avg
-99.8%
(Slower)
Current Ratio
1.31
This Stock
vs
3.83
Sector Avg
-65.9%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AGYS
Agilysys, Inc.
|
BEARISH | $1.93B | 64.01 | 10.7% | 9.8% | $68.49 | |
|
MXL
MaxLinear, Inc.
|
NEUTRAL | $1.93B | - | -28.2% | -29.2% | $21.56 | Compare |
|
ALKT
Alkami Technology, Inc.
|
BEARISH | $1.91B | - | -13.3% | -10.7% | $18.0 | Compare |
|
FORTY
Formula Systems (1985) Ltd.
|
BEARISH | $1.91B | 54.11 | 6.9% | 23.1% | $124.45 | Compare |
|
APPN
Appian Corporation
|
NEUTRAL | $1.89B | 1279.5 | -% | 0.2% | $25.59 | Compare |
AGYS
Agilysys, Inc.
BEARISH
Mkt Cap
$1.9B
P/E
64.0
ROE
10.7%
Price
$68.49
Past News Coverage
Recent headlines mentioning AGYS from our newsroom.
Newest → oldest
No matching news yet.